课题基金 / 基金详情

项目摘要

项目成果

WILLIAM E MILLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pertussis toxin (PTX) is a complex AB5 toxin, comprised of the enzymatically active, ¿A¿ subunit (S1), and the binding, ¿B¿ oligomer (PTX-B), composed of five subunits S2, S3, S4, and S5, found in a 1:1:2:1 ratio. The B portions of AB toxins transport the A subunit to the cytoplasm of target cells, and were not thought to participate in toxicity. However PTX-B has been shown to have activity in addition to its role in facilitating entry of S1 into the cytoplasm. PTX-B induces a spectrum of cellular responses, including immediate cell death, development of apoptosis, cellular clustering, and even cellular proliferation. In this proposal we will identify the receptors for PTX-B, we will characterize the signaling pathways that are affected by binding of PTX-B using T cells as a model system, and we will characterize its toxicity to other cells of the immune system. Specific Aim 1. Characterization of the PTX-B binding elements. PTX-B has been shown to bind to multiple receptors on cells. We will identify the essential PTX-B binding regions as a prelude to the identification of potential cell surface receptors. Specific Aim 2. Determine the mechanism by which PTX-B attenuates chemokine receptor signaling and chemotaxis. The mechanism by which PTX-B affects chemokine receptor activity remains largely unknown. We will extend our studies on the mechanism(s) of PTX-B signaling in T-cells to determine if PTX-B blocks lymphocyte migration by promoting chemokine receptor desensitization using the chemokine receptor CCR5 as a model system. Specific Aim 3. Characterize the ability of primary cells to respond to intact pertussis toxin and PTX-B. Published reports suggest that the responses to PTX-B are different between mice and humans. We propose to characterize the short term and long-term responses of human and murine leukocytes both intact pertussis toxin and PTX-B.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of the role of HDAC activity in regulation of HCMV replication in the salivary epithelium
  • 批准号:
    10739852
  • 项目类别:
  • 资助金额:
    $24.3万
  • 财政年份:
    2023
  • 负责人:
    WILLIAM E MILLER
  • 依托单位:
Mechanisms of vGPCR mediated Cytomegalovirus Growth in the Salivary Gland
  • 批准号:
    10180884
  • 项目类别:
  • 资助金额:
    $40.11万
  • 财政年份:
    2018
  • 负责人:
    WILLIAM E MILLER
  • 依托单位:
Development of salisphere-derived systems for the study of cytomegalovirus vGPCR directed viral growth in the salivary gland
  • 批准号:
    9317077
  • 项目类别:
  • 资助金额:
    $24.53万
  • 财政年份:
    2017
  • 负责人:
    WILLIAM E MILLER
  • 依托单位:
Mechanisms of vGPCR mediated Cytomegalovirus Growth in the Salivary Gland
  • 批准号:
    9332531
  • 项目类别:
  • 资助金额:
    $39.5万
  • 财政年份:
    2016
  • 负责人:
    WILLIAM E MILLER
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: